Tags: Drug.

Ezlopitant (CJ-11974) is an NK1 receptor antagonist. It has antiemetic and antinociceptive effects. Pfizer was developing ezlopitant for the treatment of irritable bowel syndrome but it appears to have been discontinued.

Ezlopitant.png
ATC prefix
none
CAS number
147116-64-1
FDA UNII code
3L098A8MPY
IUPAC name
(2S3S)-2-benzhydryl-N-[(5-isopropyl-2-methoxy-phenyl)methyl]quinuclidin-3-amine
PubChem
188927

Loading...

This page contains content from the copyrighted Wikipedia article "Ezlopitant"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.